首页> 外文期刊>The Thoracic and cardiovascular surgeon >Survival following Multimodality Treatment Including Surgery for Stage IA-IIIB Small-Cell Lung Cancer
【24h】

Survival following Multimodality Treatment Including Surgery for Stage IA-IIIB Small-Cell Lung Cancer

机译:多层治疗后的存活包括阶段IA-IIIB小细胞肺癌的手术

获取原文
获取原文并翻译 | 示例
           

摘要

Background Prognosis in limited disease small-cell lung cancer (SCLC) after concurrent chemoradiotherapy is poor. While some studies show better survival after multimodality treatment including surgery, other trials failed to prove a surgery-related survival benefit. Therefore, this study investigated survival in stage IA-IIIB SCLC following surgery combined with chemotherapy and/or thoracic radiotherapy.
机译:背景技术在有限疾病中的预后小细胞肺癌(SCLC)并发化学疗法较差。 虽然一些研究表明在包括手术的多层治疗后更好的存活,但其他试验未能证明与外科有关的生存效果。 因此,本研究在手术结合化疗和/或胸部放射治疗后研究了IA-IIIB SCLC期的存活。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号